Prof. Catharina Svanborg appointed as Chief Medical Officer of HAMLET Pharma, overseeing clinical trials
HAMLET Pharma has formally appointed Prof Catharina Svanborg Chief Medical Officer (CMO) of the company. The company thereby ensures that Prof. Svanborg, who is the company Chairman and founder of HAMLET Pharma, will continue and further develop her involvement in research and drug development. Specifically, this step allows the company to ensure critical coordination and oversight of clinical trials and regulatory processes.Prof Svanborg says, “Clinical trials are already underway at the University Hospital in Prague. The physicians there are committed and truly excited about the unique